April 10, 2018 / 3:33 AM / 8 months ago

BRIEF-Hunan Er-Kang Pharmaceutical sees FY 2018 Q1 net profit down 28 pct to 48 pct

April 10(Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd

* Sees FY 2018 Q1 net profit to decrease by 28 percent to 48 percent, or to be 101.1 million yuan to 140 million yuan

* Says FY 2017 Q1 net profit was 194.5 million yuan

Source text in Chinese: goo.gl/mEJNya

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below